Recently stock market analysts have updated their consensus ratings on shares of Credicorp Ltd. (NYSE:BAP). The latest broker reports which are currently outstanding on Monday 9th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

03/24/2016 – Credicorp Ltd. had its “hold” rating reiterated by analysts at Santander.

03/15/2016 – Credicorp Ltd. had its “outperform” rating reiterated by analysts at Scotiabank.

03/15/2016 – Credicorp Ltd. had its “overweight” rating reiterated by analysts at Barclays. They now have a USD 149 price target on the stock.

11/18/2015 – Credicorp Ltd. had its “outperform” rating reiterated by analysts at Credit Suisse. They now have a USD 154 price target on the stock.

09/11/2015 – Credicorp Ltd. was upgraded to “overweight” by analysts at Morgan Stanley.

05/01/2015 – Credicorp Ltd. had its “sell” rating reiterated by analysts at Zacks.

01/08/2015 – Credicorp Ltd. had its “neutral” rating reiterated by analysts at JP Morgan. They now have a USD 179 price target on the stock.

11/26/2014 – Credicorp Ltd. had its “buy” rating reiterated by analysts at UBS. They now have a USD 192.5 price target on the stock.

11/25/2014 – Credicorp Ltd. had its “overweight” rating reiterated by analysts at HSBC. They now have a USD 196 price target on the stock.

09/12/2014 – Credicorp Ltd. had its “buy” rating reiterated by analysts at Goldman Sachs. They now have a USD 187 price target on the stock.

Credicorp Ltd. has a 50 day moving average of 135.70 and a 200 day moving average of 114.42. The stock’s market capitalization is 11.13B, it has a 52-week low of 81.78 and a 52-week high of 155.62.

The share price of the company (NYSE:BAP) was up +2.46% during the last trading session, with a high of 140.30 and the volume of Credicorp Ltd. shares traded was 377798.

View other investors thoughts on Credicorp Ltd. on our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.